SCHEMBL10183947

SCHEMBL10183947

C=C/C(=C(\C)F)N(C(=O)Cc1cccs1)C1C(=O)N(C2CCCC2)c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.38
▸ OPRM1 P35372 3/20 0.35
▸ OPRK1 P41145 3/20 0.35
▸ OPRL1 P41146 2/20 0.35
▸ ALDH1A1 P00352 3/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ MCHR1 Q99705 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CYP3A4 P08684 1/20 0.32
▸ OPRD1 P41143 1/20 0.32
▸ LMNA P02545 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ CHRM1 P11229 1/20 0.31
▸ CHRM3 P20309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183787 0.99 SIGMAR1 (0.37) SIGMAR1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10183656 0.86 SIGMAR1 (0.39) SIGMAR1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10184045 0.77 OPRM1 (0.42) SIGMAR1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10185637 0.76 SIGMAR1 (0.37) SIGMAR1ALDH1A1NPSR1GAAMEN1
SCHEMBL10184154 0.74 POLB (0.39) SIGMAR1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10185926 0.74 OPRM1 (0.39) SIGMAR1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10183666 0.74 OPRM1 (0.39) SIGMAR1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10185945 0.74 OPRM1 (0.39) SIGMAR1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10183670 0.73 TRPM8 (0.41) SIGMAR1OPRM1OPRK1OPRL1NPSR1
SCHEMBL10185544 0.73 OPRM1 (0.40) SIGMAR1OPRM1OPRK1ALDH1A1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback